Saturday - March 21, 2026

Atopic Dermatitis Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | GlaxoSmithKline PLC, Nestle SA, Pfizer Inc., Regeneron Pharma, Abbvie

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Atopic Dermatitis pipeline constitutes 100+ key companies continuously working towards developing 120+ Atopic Dermatitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading

Complement 3 Glomerulopathy Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | NovelMed Therapeutics, Apellis Pharma, Novartis, Amyndas Pharma

The Key Complement 3 Glomerulopathy Companies in the market include – NovelMed Therapeutics, Apellis Pharmaceuticals, Novartis, Amyndas Pharmaceuticals, and others.   DelveInsight’s “Complement 3 Glomerulopathy Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Complement 3 … Continue reading

Diabetic Foot Ulcers Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Topadur Pharma, Cynata Therapeutics, Transwell Biotech, Aposcience, Ilya Pharma, Microbion Corp

The Key Diabetic Foot Ulcers Companies in the market include – Amniox (TissueTech), Topadur Pharma, Cynata Therapeutics, Transwell Biotech, Aposcience, Ilya Pharma, Microbion Corporation, MediWound, Paracrine, INC., NovaLead Pharma, and others.   The Diabetic Foot Ulcers market is expected to … Continue reading

Advanced Renal Cell Carcinoma Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Molecure S.A., Daiichi Sankyo, Janux Therapeutics, NiKang Therapeuti

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Advanced Renal Cell Carcinoma pipeline constitutes 50+ key companies continuously working towards developing 60+ Advanced Renal Cell Carcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of … Continue reading

Myelofibrosis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Galecto Biotech, Lynk Pharma, Samus Therapeutics, Taiga Biotech, Bristol-Mye

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Myelofibrosis pipeline constitutes 35+ key companies continuously working towards developing 40+ Myelofibrosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   … Continue reading

Head and Neck Cancer Clinical Pipeline Accelerates: Over 80 Companies Advancing 100+ Innovative Therapies | DelveInsight

Head and Neck Cancer Pipeline Major Head and Neck Cancer companies driving innovation include Merus, Bicara Therapeutics, Kura Oncology, Theriva Biologics, Nykode Therapeutics, Cue Biopharma, BioNTech, Exelixis, AstraZeneca, Johnson & Johnson, AbbVie, Iovance Biotherapeutics, Immutep, Pyxis Oncology, ALX Oncology, iTeos … Continue reading

Muscle Invasive Bladder Cancer Market Set for Strong Growth Through 2034, Driven by Expanding Pipeline and Innovation | DelveInsight

Muscle Invasive Bladder Cancer Market The Muscle Invasive Bladder Cancer (MIBC) treatment landscape is undergoing rapid transformation, fueled by an expanding pipeline and active participation from leading pharmaceutical and biotechnology companies such as CG Oncology, Pfizer, UroGen Pharma, Janssen Research … Continue reading

Hepatic Tumor Clinical Trial Landscape Strengthens as 75+ Companies Accelerate Innovation in Emerging Therapies | DelveInsight

Hepatic Tumor Pipeline Hepatic Tumor companies include Can Fite Biopharma, MiNA Therapeutics, Medivir AB, Janssen Research & Development, LLC, Etnova Therapeutics Corp., SillaJen Biotherapeutics, Akeso Biopharma, Shanghai Junshi Biosciences, Genmab/Janssen Biotech, Bio-Thera Solutions, Ocuphire Pharma, Surface Oncology, Genoscience, Onyx Pharmaceuticals, … Continue reading

Esophageal Cancer Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Eli Lilly, Amgen, Zymeworks, BeiGene

Esophageal Cancer Market Insights, Epidemiology and Market Forecast 2034 The Key Esophageal Cancer Companies in the market include – Eli Lilly and Company, Amgen, Zymeworks, Jazz Pharmaceuticals, Bayer, BeiGene, Innovent Biologics, Apexigen, and others. The Esophageal Cancer market is expected … Continue reading